CRF-CRF 1 receptor system in the central and basolateral nuclei of the amygdala differentially mediates excessive eating of palatable food

Neuropsychopharmacology

Volumn 38, Issue 12, 2013, Pages 2456-2466

  Iemolo, Attilio ^a   Blasio, Angelo ^a   St Cyr, Stephen A ^a   Jiang, Fanny ^a   Rice, Kenner C ^b   Sabino, Valentina ^a   Cottone, Pietro ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

addiction; anxiety; BNST; corticotropin releasing factor; hypophagia; rat

Indexed keywords

3 (6 DIMETHYLAMINO 4 METHYL 3 PYRIDINYL) 7 DIPROPYLAMINO 2,5 DIMETHYLPYRAZOLO[1,5 A]PYRIMIDINE; ACRYLIC CEMENT; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; RESIN; STAINLESS STEEL; SUCROSE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; PYRIMIDINE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; BASOLATERAL AMYGDALA; BED NUCLEUS OF THE STRIA TERMINALIS; BRAIN SLICE; BRAIN SURGERY; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; DIET THERAPY; DRUG MEGADOSE; FOOD INTAKE; HYPERALIMENTATION; HYPOPHAGIA; IMMUNOHISTOCHEMISTRY; INFUSION PUMP; LIGHT DARK CYCLE; MALE; MICROINJECTOR; NONHUMAN; PALATABILITY; PRIORITY JOURNAL; RAT; STRIA TERMINALIS; VENTRICULAR CANNULA (BRAIN); AMYGDALOID NUCLEUS; ANIMAL; ANXIETY; CHEMICALLY INDUCED DISORDER; DIET; DRUG ANTAGONISM; DRUG EFFECT; EATING; METABOLISM; PHYSIOLOGY; SEPTUM NUCLEUS; SUGAR INTAKE; WISTAR RAT;

AMYGDALA; ANIMALS; ANXIETY; CORTICOTROPIN-RELEASING HORMONE; DIET; DIETARY SUCROSE; EATING; MALE; PYRIMIDINES; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SEPTAL NUCLEI;

EID: 84888373967     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2013.147     Document Type: Article

References (49)

1. Ahmed SH, Koob GF (2005). Transition to drug addiction: a negative reinforcement model based on an allostatic decrease in reward function. Psychopharmacology (Berl) 180: 473-490. (Pubitemid 40905037)
2. Avena NM, Bocarsly ME, Hoebel BG (2012). Animal models of sugar and fat bingeing: relationship to food addiction and increased body weight. Methods Mol Biol 829: 351-365.
3. Bakshi VP, Kalin NH (2000). Corticotropin-releasing hormone and animal models of anxiety: gene-environment interactions. Biol Psychiatry 48: 1175-1198. (Pubitemid 32010706)
4. Bale TL (2005). Sensitivity to stress: dysregulation of CRF pathways and disease development. Horm Behav 48: 1-10. (Pubitemid 40779285)
5. Blasio A, Iemolo A, Sabino V, Petrosino S, Steardo L, Rice KC (2013a). Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdala. Neuropsychopharmacology (doi:10.1038/npp.2013.153).
6. Blasio A, Steardo L, Sabino V, Cottone P (2013b). Opioid system in the medial prefrontal cortex mediates binge-like eating. Addict Biol (doi:10.1111/adb.12033).
7. Breese GR, Overstreet DH, Knapp DJ (2005). Conceptual framework for the etiology of alcoholism: a 'kindling'/stress hypothesis. Psychopharmacology (Berl) 178: 367-380. (Pubitemid 40486977)
8. Bruijnzeel AW, Ford J, Rogers JA, Scheick S, Ji Y, Bishnoi M et al (2012). Blockade of CRF1 receptors in the central nucleus of the amygdala attenuates the dysphoria associated with nicotine withdrawal in rats. Pharmacol Biochem Behav 101: 62-68.
9. Chen C, Wilcoxen KM, Huang CQ, Xie YF, McCarthy JR, Webb TR et al (2004). Design of 2,5-dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7- dipropylaminopyrazolo[1,5-a]py rimidine (NBI 30775/R121919) and structure-activity relationships of a series of potent and orally active corticotropin-releasing factor receptor antagonists. J Med Chem 47: 4787-4798. (Pubitemid 39195568)
10. Corwin RL (2006). Bingeing rats: a model of intermittent excessive behavior Appetite 46: 11-15. (Pubitemid 43042340)
11. Corwin RL, Grigson PS (2009). Symposium overview-food addiction: fact or fiction J Nutr 139: 617-619.
12. Cottone P, Sabino V, Nagy TR, Coscina DV, Zorrilla EP (2007). Feeding microstructure in diet-induced obesity susceptible versus resistant rats: central effects of urocortin 2. J Physiol 583(Pt 2): 487-504. (Pubitemid 47343486)
13. Cottone P, Sabino V, Roberto M, Bajo M, Pockros L, Frihauf JB et al (2009a). CRF system recruitment mediates dark side of compulsive eating. Proc Natl Acad Sci USA 106: 20016-20020.
14. Cottone P, Sabino V, Steardo L, Zorrilla EP (2008). Intermittent access to preferred food reduces the reinforcing efficacy of chow in rats. Am J Physiol Regul Integr Comp Physiol 295: R1066-R1076.
15. Cottone P, Sabino V, Steardo L, Zorrilla EP (2009b). Consummatory, anxiety-related and metabolic adaptations in female rats with alternating access to preferred food. Psychoneuroendocrinology 34: 38-49.
16. Cottone P, Wang X, Park JW, Valenza M, Blasio A, Kwak J et al (2012). Antagonism of sigma-1 receptors blocks compulsive-like eating. Neuropsychopharmacology 37: 2593-2604.
17. Dore R, Iemolo A, Smith KL, Wang X, Cottone P, Sabino V (2013). CRF mediates the anxiogenic and anti-rewarding, but not the anorectic effects of PACAP. Neuropsychopharmacology (doi:10.1038/npp.2013.113).
18. Funk CK, O'Dell LE, Crawford EF, Koob GF (2006). Corticotropinreleasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J Neurosci 26: 11324-11332. (Pubitemid 44772162)
19. George O, Ghozland S, Azar MR, Cottone P, Zorrilla EP, Parsons LH et al (2007). CRF-CRF1 system activation mediates withdrawalinduced increases in nicotine self-administration in nicotinedependent rats. Proc Natl Acad Sci USA 104: 17198-17203. (Pubitemid 350211014)
20. Grigoriadis DE, Chen C, Wilcoxen K, Chen T, Lorang MT, Bozigion H et al (2000). In vitro characterization of R121919: a novel nonpeptide corticotropin-releasing factor1 (CRF1) receptor antagonist for the potential treatment of depression and anxiety-related disorders. Society for Neuroscience Abstract 807: 4-9.
21. Hagan MM, Chandler PC, Wauford PK, Rybak RJ, Oswald KD (2003). The role of palatable food and hunger as trigger factors in an animal model of stress induced binge eating. Int J Eat Disord 34: 183-197. (Pubitemid 36935720)
22. Hatfield T, Han JS, Conley M, Gallagher M, Holland P (1996). Neurotoxic lesions of basolateral, but not central, amygdala interfere with Pavlovian second-order conditioning and reinforcer devaluation effects. J Neurosci 16: 5256-5265. (Pubitemid 26269683)
23. Heilig M, Egli M, Crabbe JC, Becker HC (2010). Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked Addict Biol 15: 169-184.
24. Heilig M, Koob GF (2007). A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci 30: 399-406. (Pubitemid 47090230)
25. Heinrichs SC, Menzaghi F, Schulteis G, Koob GF, Stinus L (1995). Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav Pharmacol 6: 74-80.
26. Iemolo A, Valenza M, Tozier L, Knapp CM, Kornetsky C, Steardo L et al (2012). Withdrawal from chronic, intermittent access to a highly palatable food induces depressive-like behavior in compulsive eating rats. Behav Pharmacol 23: 593-602.
27. Koob GF (2008). A role for brain stress systems in addiction. Neuron 59: 11-34. (Pubitemid 351905857)
28. Koob GF (2009). Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology 56(Suppl 1): 18-31.
29. Koob GF (2010). The role of CRF and CRF-related peptides in the dark side of addiction. Brain Res 1314: 3-14.
30. Koob GF, Heinrichs SC (1999). A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res 848: 141-152. (Pubitemid 30001663)
31. Koob GF, Le Moal M (2005). Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat Neurosci 8: 1442-1444. (Pubitemid 41573653)
32. Koob GF, Le Moal M (2008). Review. Neurobiological mechanisms for opponent motivational processes in addiction. Philos Trans R Soc Lond B Biol Sci 363: 3113-3123.
33. Koob GF, Volkow ND (2010). Neurocircuitry of addiction. Neuropsychopharmacology 35: 217-238.
34. Logrip ML, Koob GF, Zorrilla EP (2011). Role of corticotropinreleasing factor in drug addiction: potential for pharmacological intervention. CNS Drugs 25: 271-287.
35. Maj M, Turchan J, Smialowska M, Przewlocka B (2003). Morphine and cocaine influence on CRF biosynthesis in the rat central nucleus of amygdala. Neuropeptides 37: 105-110. (Pubitemid 37421493)
36. McNally GP, Akil H (2002). Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal. Neuroscience 112: 605-617. (Pubitemid 34634154)
37. Merlo Pich E, Lorang M, Yeganeh M, Rodriguez de Fonseca F, Raber J, Koob GF et al (1995). Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci 15: 5439-5447.
38. Murray E, Wise S, Rhodes S (2011). What can different brains do with reward In Gottfried JA (eds). Neurobiology of Sensation and Reward, Chapter 4. CRC Press: Boca Raton, FL, USA.
39. Parylak SL, Koob GF, Zorrilla EP (2011). The dark side of food addiction. Physiol Behav 104: 149-156.
40. Paxinos G, Watson C (2007). The Rat Brain in Stereotaxic Coordinates, 6th edn. Academic Press.
41. Pellegrino A (1979). A Stereotaxic Atlas of the Rat Brain. Plenum: New York.
42. Rodriguez de Fonseca F, Carrera MR, Navarro M, Koob GF, Weiss F (1997). Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 276: 2050-2054. (Pubitemid 27443612)
43. Sabino V, Cottone P, Steardo L, Schmidhammer H, Zorrilla EP (2007). 14-Methoxymetopon, a highly potent mu opioid agonist, biphasically affects ethanol intake in Sardinian alcoholpreferring rats. Psychopharmacology (Berl) 192: 537-546. (Pubitemid 46870748)
44. Salinas JA, Parent MB, McGaugh JL (1996). Ibotenic acid lesions of the amygdala basolateral complex or central nucleus differentially effect the response to reductions in reward. Brain Res 742: 283-293. (Pubitemid 27016033)
45. Shalev U, Erb S, Shaham Y (2010). Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking. Brain Res 1314: 15-28.
46. Vale W, Spiess J, Rivier C, Rivier J (1981). Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213: 1394-1397. (Pubitemid 12243637)
47. Volkow ND, O'Brien CP (2007). Issues for DSM-V: should obesity be included as a brain disorder Am J Psychiatry 164: 708-710. (Pubitemid 46808521)
48. Wellman LL, Gale K, Malkova L (2005). GABAA-mediated inhibition of basolateral amygdala blocks reward devaluation in macaques. J Neurosci 25: 4577-4586. (Pubitemid 40629148)
49. Yach D, Stuckler D, Brownell KD (2006). Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 12: 62-66. (Pubitemid 43050076)